New 3D mapping and dye technique could make lung cancer surgery safer and more precise

NCT ID NCT03953144

Recruiting now Symptom relief Sponsor: St. Joseph's Healthcare Hamilton Source: ClinicalTrials.gov ↗

First seen Feb 02, 2026 · Last updated Apr 29, 2026 · Updated 12 times

Summary

This study tests a new way to perform lung cancer surgery for early-stage non-small cell lung cancer. Doctors will use a 3D computer model (Synapse 3D) and a green dye injected into the blood to see exactly which part of the lung needs to be removed. The goal is to make surgery more precise, reduce complications, and help patients recover faster. About 32 adults with small tumors (under 3 cm) will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

St. Josephs Healthcare Hamilton
RECRUITING

Hamilton, Ontario, L8N 4A6, Canada

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CANCER PRIMARY NEOPLASM